<DOC>
	<DOCNO>NCT01913184</DOCNO>
	<brief_summary>To compare continuous sicontinuous delivery drug AKITA .</brief_summary>
	<brief_title>Lung Bioavailability With Continuous Discontinuous Nebulization</brief_title>
	<detailed_description />
	<criteria>lung disease allergy smoker</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>